Last updated: 19 March 2021 at 6:30pm EST

John Limongelli Net Worth




The estimated Net Worth of John M Limongelli is at least $626 mil dollars as of 12 December 2014. Mr. Limongelli owns over 3,000 units of Neos Therapeutics Inc stock worth over $13,800 and over the last 11 years he sold NEOS stock worth over $0. In addition, he makes $612,458 as Senior Vice President e General Counsel and Corporate Secretary at Neos Therapeutics Inc.

Mr. Limongelli NEOS stock SEC Form 4 insiders trading

John has made over 2 trades of the Neos Therapeutics Inc stock since 2014, according to the Form 4 filled with the SEC. Most recently he bought 3,000 units of NEOS stock worth $12,420 on 12 December 2014.

The largest trade he's ever made was buying 9,000 units of Neos Therapeutics Inc stock on 10 December 2014 worth over $36,000. On average, John trades about 923 units every 0 days since 2014. As of 12 December 2014 he still owns at least 12,000 units of Neos Therapeutics Inc stock.

You can see the complete history of Mr. Limongelli stock trades at the bottom of the page.





John Limongelli biography

John M. Limongelli Esq., J.D. CPA serves as Senior Vice President, General Counsel and Corporate Secretary of the Company. Mr. Limongelli has served as our Senior Vice President, General Counsel since March 2019. Prior to joining us, he was Senior Vice President, General Counsel & Chief Administrative Officer at Trevena, Inc. (NASDAQ: TRVN) from May 2014 to March 2019. Prior to this, he was Vice President, Associate Chief Counsel and Corporate Secretary at Cigna Corporation (NYSE: CI) from September 2013 until May 2014. From October 2012 to September 2013, he was a partner at a Philadelphia-area law firm, and from September 2008 to December 2011, he served as Senior Vice President, General Counsel and Secretary at Adolor Corporation. Prior to this, Mr. Limongelli held roles of increasing responsibility with Cephalon, Inc. Mr. Limongelli began his legal career in private practice with Morgan, Lewis & Bockius, LLP. Before his legal career, Mr. Limongelli was a certified public accountant with KPMG LLP. Mr. Limongelli obtained both his J.D. and M.B.A. from Temple University.

What is the salary of John Limongelli?

As the Senior Vice President e General Counsel and Corporate Secretary of Neos Therapeutics Inc, the total compensation of John Limongelli at Neos Therapeutics Inc is $612,458. There are 2 executives at Neos Therapeutics Inc getting paid more, with Gerald McLaughlin having the highest compensation of $1,399,430.



How old is John Limongelli?

John Limongelli is 50, he's been the Senior Vice President e General Counsel and Corporate Secretary of Neos Therapeutics Inc since 2019. There are 7 older and 1 younger executives at Neos Therapeutics Inc. The oldest executive at Neos Therapeutics Inc is Alan Heller, 66, who is the Independent Chairman of the Board.

What's John Limongelli's mailing address?

John's mailing address filed with the SEC is C/O NEOS THERAPEUTICS, INC., 2940 N. HWY 360, GRAND PRAIRIE,, TX, 75050.

Insiders trading at Neos Therapeutics Inc

Over the last 9 years, insiders at Neos Therapeutics Inc have traded over $796,275 worth of Neos Therapeutics Inc stock and bought 558,630 units worth $7,201,055 . The most active insiders traders include Jack W Schuler, James E Deerfield Mgmt L.P...., eBryant Fong. On average, Neos Therapeutics Inc executives and independent directors trade stock every 69 days with the average trade being worth of $42,698. The most recent stock trade was executed by Richard I Eisenstadt on 12 December 2018, trading 5,000 units of NEOS stock currently worth $10,800.



What does Neos Therapeutics Inc do?



Complete history of Mr. Limongelli stock trades at Neos Therapeutics Inc e Trevena Inc

Acionista maioritário
Trans.
Transação
Preço total
John M Limongelli
Sr. VP, General Counsel, eSecy
Comprar $12,420
12 Dec 2014
John M Limongelli
Sr. VP, General Counsel, eSecy
Comprar $36,000
10 Dec 2014


Neos Therapeutics Inc executives and stock owners

Neos Therapeutics Inc executives and other stock owners filed with the SEC include: